Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lori, Carria"'
Autor:
Erin C, Cobry, Lauren G, Kanapka, Eda, Cengiz, Lori, Carria, Laya, Ekhlaspour, Bruce A, Buckingham, Korey K, Hood, Liana J, Hsu, Laurel H, Messer, Melissa J, Schoelwer, Emma, Emory, Katrina J, Ruedy, Roy W, Beck, Raj Paul, Wadwa, Linda, Gonder-Frederick, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic variability. Person-reported outcomes (PROs) are essential to assess the utility of new devices and their impact on quality of life. This article focuses on the
Autor:
Laya Ekhlaspour, Jennifer L. Sherr, Lori Carria, Bruce A. Buckingham, R. Paul Wadwa, Alfonso Galderisi, Lauren M. Huyett, Cari Berget, Gregory P. Forlenza, Thomas A. Peyser, Bonnie Dumais, Liana Hsu, Jason O'Connor, Trang T. Ly, Jennifer E. Layne, Joon Bok Lee
Publikováno v:
Diabetes Technology & Therapeutics
Background: The objective of this study was to assess the safety and performance of the Omnipod® personalized model predictive control (MPC) algorithm in adults, adolescents, and children aged ≥6 years with type 1 diabetes (T1D) under free-living
Autor:
Gabriel Betancur, Kerry R. Stephenson, Kate Weyman, Michelle A. Van Name, Lori Carria, Michelle N. Brei, Jennifer L. Sherr
Publikováno v:
Diabetes. 70
Youth newly diagnosed with T1D, and their families, require intensive education on management of this chronic condition. Traditionally, our center has conducted many hours of in-person training during a hospital admission. We studied family perceptio
Autor:
Sunil Deshpande, Stuart A. Weinzimer, Kathryn Gibbons, Laura M. Nally, Kate Weyman, Lori Carria, Melinda Zgorski, Lori M. Laffel, Francis J. Doyle, Eyal Dassau
Publikováno v:
Journal of Diabetes Science and Technology. :193229682211163
Background: A smartphone-based automated insulin delivery (AID) controller device can facilitate use of interoperable components and acceptance in adolescents and children. Methods: Pediatric participants (N = 20, 8F) with type 1 diabetes were enroll
Autor:
Melissa J, Schoelwer, Lauren G, Kanapka, R Paul, Wadwa, Marc D, Breton, Katrina J, Ruedy, Laya, Ekhlaspour, Gregory P, Forlenza, Erin C, Cobry, Laurel H, Messer, Eda, Cengiz, Emily, Jost, Lori, Carria, Emma, Emory, Liana J, Hsu, Stuart A, Weinzimer, Bruce A, Buckingham, Rayhan A, Lal, Mary Clancy, Oliveri, Craig C, Kollman, Betsy B, Dokken, Daniel R, Cherñavvsky, Roy W, Beck, Mark D, DeBoer, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in user
Publikováno v:
Contemporary Endocrinology ISBN: 9783030641320
Despite improvements in diabetes therapy provided by insulin pumps and continuous glucose monitoring (CGM) devices, most youth with T1D do not meet glycemic targets. For example, recent data from the T1D Exchange Registry continue to demonstrate that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf03dd69f757e60d97e9a6be2033edf7
https://doi.org/10.1007/978-3-030-64133-7_8
https://doi.org/10.1007/978-3-030-64133-7_8
Autor:
the iDCL Trial Research Group, Roy W. Beck, Daniel Cherñavvsky, Betsy B. Dokken, Craig Kollman, Mary Oliveri, Bruce A. Buckingham, Mark D. DeBoer, Stuart A. Weinzimer, Liana J. Hsu, Emma Emory, Lori Carria, Emily Jost, Melissa J. Schoelwer, Eda Cengiz, Gregory P. Forlenza, Laya Ekhlaspour, Katrina J. Ruedy, Marc D. Breton, R. Paul Wadwa, Lauren G. Kanapka
Objective: To further evaluate the safety and efficacy of the Control-IQ closed loop control (CLC) system in children with type 1 diabetes. Research Design and Methods: Following a 16-week randomized clinical trial (RCT) comparing CLC with sensor aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5edbd08406fd9aaa7a8035cc8b6acc
https://doi.org/10.2337/figshare.13260212.v1
https://doi.org/10.2337/figshare.13260212.v1
Autor:
Stuart A. Weinzimer, Jennifer L. Sherr, Eda Cengiz, Lori Carria, Michelle A. Van Name, William V. Tamborlane, Neha S. Patel
Publikováno v:
Diabetes Technology & Therapeutics. 19:618-622
Enthusiasm for the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) as an adjunctive treatment in type 1 diabetes (T1D) has been offset by the possible increased risk of diabetic ketoacidosis (DKA). Since pump-treated T1D patients are s
Autor:
Alfonso Galderisi, Jennifer L. Sherr, Neha S. Patel, William V. Tamborlane, Stephan Siebel, Lori Carria
Objective: We have shown that “euglycemic DKA” in patients with type 1 diabetes receiving a sodium–glucose cotransporter 2-inhibitor (SGLT2i) is due to normal increases in rates of ketogenesis but blunted increases in plasma glucose levels. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2fb92998e555d226ede2bd15dfa944
https://europepmc.org/articles/PMC6434586/
https://europepmc.org/articles/PMC6434586/
Autor:
Jennifer L. Sherr, Martin Cantwell, Lori Carria, Bruce A. Buckingham, Trang T. Ly, David M. Maahs, Benyamin Grosman, Laurel H. Messer, Natalie Kurtz, Anirban Roy, Rie von Eyben, Stuart A. Weinzimer
Publikováno v:
Pediatric Diabetes. 18:348-355
Background Automated insulin delivery systems, utilizing a control algorithm to dose insulin based upon subcutaneous continuous glucose sensor values and insulin pump therapy, will soon be available for commercial use. The objective of this study was